“The USA vitiligo trial is powering on. Those recent patient...

First 12 Last

Share
Profile

Follow
J_Bee

18 Posts.

1

13/03/24

00:08

Post #: 72857254
Share

Originally posted by minutesoup: ↑

The USA vitiligo trial is powering on. Those recent patient data are in one word impressive. Cuv is training and certifying vitiligo centers for a reason. They must be very confident that the fda will approve scenesse for vitiligo. The vast amount of positive scientific data gathered by cuv and the regulators must at some point allow a wider use of scenesse. Hard to believe that only one analyst incorporates the vitiligo potential. Show me an other biotech that is getting fast approvals year after year. They all have the same problems of extreme slowness of regulatory action and high uncertainty of timing and outcome.

Also in the EU we are still waiting for the EMA to allow use for adolescent EPP patients. VP and XP could already be allowed on a compassionate basis imho. Just keep collecting that valuable scientific patient data!

Clinuvel has only one shot at getting the cosm etics right. Timing is all. To have lady Gaga say something is one thing but they failed to present any truly groundbreaking cosmetic product. So for me the recent event was a missed chance, it came to early because we don't have the M line yet. I did not see or hear any follow up or any "masterplan". Next time I hope lady Gaga pushes the "add to cart" button on the webstore.

Expand

“The USA vitiligo trial is powering on. Those recent patient data are in one word impressive. Cuv is training and certifying vitiligo centers for a reason. They must be very confident that the fda will approve scenesse for vitiligo.”

I didn’t know they were training and certifying vitiligo centres. Was that announced officially?

Would these centres be in the same location as the EPP ones?

CUV Price at posting: $13.32 Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply